title: Necrosis of uninvolved bone marrow following filgrastim administration in a patient with Burkitt lymphoma undergoing chemotherapy.
authors.affiliation: Hematology Oncology Section, Department of Internal Medicine, Minneapolis VA Medical Center, University of Minnesota, Minneapolis, MN, USA.
authors.forename: Li
authors.initials: L
authors.lastname: Ding
authors.forename: Ajay
authors.initials: A
authors.lastname: Rawal
authors.forename: Sharon
authors.initials: S
authors.lastname: Luikart
authors.forename: Punit
authors.initials: P
authors.lastname: Wadhwa
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects* / Q000473:pathology*; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000473:pathology*; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim